The close ties of iron to the pathological proteins (Robinson et al., 2018), Aβ, tau, α-synuclein and TDP43, means that successful therapeutic targets involving iron biology would be translatable to several neurodegenerative diseases. The gene discussed is MAPT; the disease is neurodegenerative disease.